European Patent Office

T 0857/06 (TNF binding protein II/YEDA) vom 05.06.2008

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2008:T085706.20080605
Datum der Entscheidung
5. Juni 2008
Aktenzeichen
T 0857/06
Antrag auf Überprüfung von
-
Anmeldenummer
90109337.7
IPC-Klasse
C12P 21/02
Verfahrenssprache
Englisch
Verteilung
An die Kammervorsitzenden und -mitglieder verteilt (B)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
Tumor necrosis factor binding protein II, its purification and antibodies thereto
Name des Antragstellers
YEDA RESEARCH AND DEVELOPMENT CO., LTD.
Name des Einsprechenden
ABBOTT GmbH & Co. KG
Kammer
3.3.04
Leitsatz
-
Relevante Rechtsnormen
European Court of Human Rights judgements Borgers v. Belgium of 30 October 1991, Kress v. France of 7 June 2001 and Martinie v. France of 12 April 2006, England and Wales Court of Appeal judgement Parker v. The Law Society of 4 December 1998European Patent Convention Art 106(2)European Patent Convention Art 112a(2)(b)European Patent Convention Art 54(3)European Patent Convention Art 83 1973Rules of procedure of the Boards of Appeal Art 19(1)
Schlagwörter
Presence of assistant at deliberations (yes)
Appealability of interlocutory decision (yes)
Added subject-matter (no)
Sufficiency of disclosure (yes)
Novelty (yes)
Orientierungssatz
1. The discretion under Article 19(1), second sentence, RPBA may be exercised to allow the board's assistant to attend and to take part in the deliberations (see points 1 to 6).
2. A first interlocutory decision which does not allow a separate appeal can be appealed together with a second interlocutory decision which does not leave any substantive issues outstanding and which allows a separate appeal (see points 7 to 11).
Zitierende Akten
T 1954/14

ORDER

For these reasons it is decided that:

1. The decisions under appeal are set aside.

2. The case is remitted to the department of first instance with the order to maintain the patent in amended form on the basis of claims 1 to 33 of the new main request filed with the grounds of appeal of appellant I and a description yet to be adapted.